Market Research Report
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 128 Pages
Delivery time: 1-2 business days
Global Plasma Therapy Market to Reach $470.6 Million by 2027
Amid the COVID-19 crisis, the global market for Plasma Therapy estimated at US$195.9 Million in the year 2020, is projected to reach a revised size of US$470.6 Million by 2027, growing at a CAGR of 13.3% over the analysis period 2020-2027. Pure PRP, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$232.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Leukocyte-Rich PRP segment is readjusted to a revised 15.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $57.8 Million, While China is Forecast to Grow at 12.9% CAGR
The Plasma Therapy market in the U.S. is estimated at US$57.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$82.4 Million by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 11.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.
Pure Platelet-Rich Fibrin Segment to Record 13.6% CAGR
In the global Pure Platelet-Rich Fibrin segment, USA, Canada, Japan, China and Europe will drive the 13.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$22.5 Million in the year 2020 will reach a projected size of US$54.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$56.2 Million by the year 2027.
Select Competitors (Total 38 Featured) -